In mLNs, we detected significant effects of treatment on both CD4+ and CD8+ T-cells, of which the CD4+ T-cells were higher and CD8+ T-cells lower in the AOM/DSS-treated mice (Figure 4c). The gene discussed is CD8A; the disease is infectious otitis media.